Streetbeat News

Revenues

MRNA

Analysts have provided mixed reviews on Moderna (NASDAQ:MRNA) over the past three months, with 7 total ratings ranging from bullish to indifferent. The average 12-month price target for MRNA is now $123.43, down from $157.75, with a high estimate of $231.00 and a low of $69.00. Moderna's financial performance shows challenges, with a -44.5% revenue decline as of September 30, 2023, a net margin of -203.13%, and an ROE of -23.88%. The company's debt-to-equity ratio is low at 0.11, indicating cautious financial management.

Portfolio Pulse from Benzinga Insights

January 12, 2024 | 5:00 pm

ZM

Zoom Video Communications (NASDAQ:ZM) has received mixed analyst ratings over the last quarter, with 10 experts providing varied opinions. The recent ratings show a shift towards a more indifferent stance, with 7 indifferent ratings in the last two months. The 12-month price targets suggest a slight decrease in the average target to $74.5, down from $75.00. Analysts have made several adjustments to their ratings and price targets, reflecting their ongoing assessment of the company's performance and market conditions. Zoom's financial indicators show positive revenue growth but below-average ROE and ROA, with a low debt-to-equity ratio indicating minimal reliance on debt financing.

Portfolio Pulse from Benzinga Insights

January 12, 2024 | 5:00 pm

MMSI

Merit Medical Systems (NASDAQ:MMSI) received varied analyst ratings in the last quarter, with an average 12-month price target of $93.00, up from the previous $88.75. Analysts from Piper Sandler, Canaccord Genuity, Barrington Research, and Needham have adjusted their price targets and ratings, reflecting changes in market conditions and company performance. Merit Medical Systems, a medical equipment company, shows strong financial health with a positive revenue trend, high net margin, and efficient debt management, despite lagging behind industry peers in revenue growth.

Portfolio Pulse from Benzinga Insights

January 12, 2024 | 4:01 pm

FIVN

Five9 (NASDAQ:FIVN) has received diverse analyst ratings over the past three months, with 11 analysts offering opinions ranging from bullish to bearish. The average 12-month price target is $88.45, with a high of $100.00 and a low of $77.00, marking a 2.27% decrease from the previous average. Analysts have adjusted their ratings and price targets, with some maintaining and others raising or lowering their stance. Five9's financial performance shows a revenue growth of 16.01% but trails behind industry peers, with a net margin of -8.87%, ROE of -4.29%, ROA of -1.43%, and a high debt-to-equity ratio of 1.61.

Portfolio Pulse from Benzinga Insights

January 12, 2024 | 4:00 pm

COO

Analysts have provided mixed reviews on Cooper Companies (NASDAQ:COO) with 4 different ratings over the past quarter. The average 12-month price target is now $387.5, down 5.1% from the previous $408.33. Piper Sandler's Jason Bednar raised the target to $440, Morgan Stanley's Patrick Wood and JP Morgan's Robbie Marcus lowered their targets to $355 and $375 respectively, and B of A Securities' Craig Bijou set a target of $380. Cooper Companies operates in eye care and women's healthcare, showing strong financial performance with a 9.31% revenue growth, a net margin of 9.11%, and a ROE of 1.12%.

Portfolio Pulse from Benzinga Insights

January 12, 2024 | 4:00 pm

DOCU

Eight analysts have recently published ratings on DocuSign (NASDAQ:DOCU), with a mix of opinions ranging from bullish to bearish. Over the past three months, sentiments have shifted, with the current distribution showing 2 somewhat bullish, 4 indifferent, and 2 somewhat bearish ratings. The 12-month price targets have an average of $54.38, with a high of $84.00 and a low of $45.00. Several analysts have maintained their ratings, while others have lowered their price targets. DocuSign's financial performance shows strong revenue growth and net margin but lags in ROE compared to industry averages. The company's market capitalization is below industry averages, and it has a conservative debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 12, 2024 | 4:00 pm

BURBY

LVMHF

PPRUY

Burberry Group PLC (OTC:BURBY) reported a 7% Y/Y decline in retail revenue and a 4% Y/Y drop in comparable store sales for the 13 weeks ending Dec. 30, 2023. The company lowered its FY24 adjusted operating profit forecast to £410-460 million, citing a slowdown in luxury goods demand. Shares fell 7% in morning trading, and other luxury stocks like LVMH (OTC:LVMHF) and Kering SA (OTC:PPRUY) also saw declines. Burberry remains committed to a £4 billion revenue target but expects currency headwinds and a high-single-digit percentage decline in wholesale revenue for FY24.

Portfolio Pulse from Lekha Gupta

January 12, 2024 | 3:57 pm

LYFT

Lyft (NASDAQ:LYFT) received mixed analyst ratings with 8 indifferent, 1 somewhat bearish, and 1 bearish out of 10 recent ratings. The average 12-month price target is $12.45, up 11.06% from the previous $11.21. Analysts from firms like Goldman Sachs, BMO Capital, and others have raised their price targets, reflecting a response to Lyft's market dynamics and performance. Lyft's financials show a revenue growth of 9.84%, a net margin of -1.05%, an ROE of -2.83%, an ROA of -0.27%, and a debt-to-equity ratio of 2.23.

Portfolio Pulse from Benzinga Insights

January 12, 2024 | 3:01 pm

WM

Waste Management (NYSE:WM) has received mixed analyst ratings over the past three months, with 9 analysts offering a range of views. The average 12-month price target is $178.78, with a high of $190.00 and a low of $163.00, indicating a 2.6% increase from the previous target. Analysts from firms like Oppenheimer, Stifel, and others have raised their price targets, reflecting a positive outlook on WM's performance. WM is a leading provider of waste services and recycling in North America, with strong financial metrics such as a net margin of 12.75% and ROE of 9.57%, but a high debt-to-equity ratio of 2.22.

Portfolio Pulse from Benzinga Insights

January 12, 2024 | 3:00 pm

RSG

Analysts have provided mixed reviews on Republic Services (NYSE:RSG) with 6 evaluations over the past three months. The average 12-month price target is $176.17, reflecting a 6.51% increase from the previous target. Analysts from firms like Oppenheimer, Stifel, Wells Fargo, and UBS have raised their price targets, indicating a positive outlook. Republic Services, a major waste services provider in the US, has shown strong financial performance with a high market cap, revenue growth of 6.34%, a net margin of 12.55%, ROE of 4.68%, ROA of 1.6%, and a low debt-to-equity ratio of 1.18.

Portfolio Pulse from Benzinga Insights

January 12, 2024 | 3:00 pm